Updated: Jun 21
Listen to Mallinckrodt Pharmaceuticals, Amsterdam UMC, Comac Medical, Peachtree, and Julius Clinical as they discussed the emerging future of outsourcing regional and global trials.
This exclusive discussion covered the topics below:
Overcoming concerns around perceived risks and inefficiencies when building tailor-made trial solutions.
How to build an outsourcing strategy that will deliver greater design flexibility and closer working with industry expert KOL’s.
Where to find the right partners who can deliver personalized access to local sites, patient populations, and scientific support.
Why developing a peer-to-peer approach with local experts results in patient-preferred trial designs, outcomes, and deliverables.
You can view the recording here: https://youtu.be/SIsFI0sgTEU